IMN || Across Specialties

Misdiagnosis, noncompliance often culprits in refractory celiac disease

Posted on: 18/12/2013 - 20:10

HOLLYWOOD, FLA. – Refractory celiac disease is often the result of patients having either received an incorrect diagnosis, or their noncompliance, according to Dr. Joseph Murray of the Mayo Clinic in...

Field of Interest: Gastroentero...

Type: News Item

FDA advisers back vedolizumab approval to treat moderate to severe inflammatory bowel disease

Posted on: 18/12/2013 - 17:10

SILVER SPRING, MD. – The benefits of vedolizumab, an integrin antagonist, outweigh the potential for progressive multifocal encephalopathy and other possible risks as a treatment for moderate to...

Field of Interest: Gastroentero...

Type: News Item

Thrombosis precautions in IBD not met in two-thirds of high-risk cases

Posted on: 17/12/2013 - 14:15

HOLLYWOOD, FLA. – The relative risk of thromboembolic events is greater in inpatient inflammatory bowel disease patients than in the general population, but prophylactic treatment is still not...

Field of Interest: Gastroentero...

Type: News Item

Esophageal ultrasound unreliable for tumor staging

Posted on: 13/12/2013 - 18:20

Endoscopic esophageal ultrasound understages many early-stage esophageal cancers, possibly leading to undertreatment for many patients, a study has shown. A review of more than 100 patients with...

Field of Interest: Gastroentero...

Type: News Item

Telaprevir label changes include switch to twice-daily dosing

Posted on: 13/12/2013 - 17:30

The label of the hepatitis C antiviral drug telaprevir has been changed to include new dosing recommendations and contraindications, described in a "Dear Healthcare Professional" letter...

Field of Interest: Gastroentero...

Type: News Item

« first
‹ previous
…
20
21
22
23
24
25
26
27
28

Newsletters

Stay informed on our latest news!

You are here

Misdiagnosis, noncompliance often culprits in refractory celiac disease

FDA advisers back vedolizumab approval to treat moderate to severe inflammatory bowel disease

Thrombosis precautions in IBD not met in two-thirds of high-risk cases

Esophageal ultrasound unreliable for tumor staging

Telaprevir label changes include switch to twice-daily dosing

Newsletters

Latest Newsletters